tiprankstipranks
Adial Pharmaceuticals Inc (ADIL)
NASDAQ:ADIL
US Market

Adial Pharmaceuticals (ADIL) Income Statement

Compare
495 Followers

Adial Pharmaceuticals Income Statement

Last quarter (Q3 2024), Adial Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Adial Pharmaceuticals's net income was $-2.19M. See Adial Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -564.00$ -60.50K$ -55.11K$ -564.00$ -565.00
Operating Expenses
$ 6.89M$ 13.32M$ 17.74M$ 10.93M$ 8.24M
Depreciation and Amortization
$ 564.00$ 564.00$ 55.11K$ 564.00$ 565.00
EBITDA
$ -7.00M$ -13.32M$ -19.46M$ -10.93M$ -8.15M
Operating Income
$ -6.89M$ -13.32M$ -19.29M$ -10.93M$ -8.24M
Other Income/Expenses
$ -113.94K$ 585.21K$ -1.82M$ 34.99K$ -346.53K
Pretax Income
$ -7.00M$ -12.73M$ -19.52M$ -10.89M$ -8.59M
Net Income
$ -7.00M$ -12.73M$ -19.42M$ -10.86M$ -8.59M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -5.44$ -11.98$ -26.12$ -21.79$ -21.80
Diluted EPS
$ -5.44$ -11.98$ -26.12$ -21.79$ -21.80
Weighted Average Shares Outstanding
1.42M 1.06M 743.55K 498.52K 394.10K
Weighted Average Shares Outstanding (Diluted)
1.42M 1.06M 743.55K 498.52K 394.10K
Currency in USD

Adial Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis